The effect of myelinating Schwann cells on axons

Muscle and Nerve

Volumn 24, Issue 4, 2001, Pages 456-466

  Martini, Rudolf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Axon glia interaction; Axonopathy; Degeneration; Inherited neuropathies; Myelin; Neurofilament; Oligodendrocytes; Phosphorylation; Schwann cell

Indexed keywords

MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN;

CELL FUNCTION; CELL SIZE; HUMAN; HUMAN CELL; MYELIN SHEATH; MYELINATION; NERVE FIBER; NERVE FIBER TRANSPORT; NEUROFILAMENT; PHOSPHORYLATION; PRIORITY JOURNAL; RANVIER NODE; REVIEW; SCHWANN CELL;

ANIMALS; AXONS; HUMANS; MICE; MYELIN PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROFILAMENT PROTEINS; PHOSPHORYLATION; POLYNEUROPATHIES; RANVIER'S NODES; SCHWANN CELLS;

EID: 0035078628     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1027     Document Type: Review

References (93)

1. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy
2. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice
3. Potential of Schwann cells from unmyelinated nerves to produce myelin: A quantitative ultrastructural and radiographic study
4. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene
5. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32
6. On the molecular architecture of myelinated fibers
7. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvβ2, and Caspr
8. Expression of janusin (J1-160/180) in the retina and optic nerve of the developing and adult mouse
9. Physiological roles of axonal ankyrins in survival of premyelinated axons and localization of voltage-gated sodium channels
10. Axonal pathology in myelin disorders
11. Formation of compact myelin is required for maturation of the axonal cytoskeleton
12. Absence of myelin-associated glycoprotein (MAG) and the neural cell adhesion molecule (N-CAM) interferes with the maintenance, but not with the formation of peripheral myelin
13. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice
14. Clustering of neuronal sodium channels requires contact with myelinating Schwann cells
15. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice
16. -) and NrCAM at nodal axon segments
17. Myelin-associated glycoprotein, MAG, selectively binds several neuronal proteins
18. Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein
19. Clustering of voltage-sensitive sodium channels on axons is independent of direct Schwann cell contact in the dystrophic mouse
20. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: The trembler as an in vivo model for Schwann cell-axon interactions
21. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
22. + channels and node of Ranvier formation in remyelinating axons
23. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS
24. Axon-glial interactions regulate the localization of axonal paranodal proteins
25. Hereditary motor and sensory neuropathies
26. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination
27. Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions
28. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy
29. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice
30. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity
31. Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: A longitudinal clinical and electrophysiologic study
32. Node-paranode regions as local degradative centres in alpha-motor axons
33. Removal of retrogradely transported material from rat lumbosacral alpha-motor axons by paranodal axon-Schwann cell networks
34. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons
35. Animal models for autoimmune demyelinating disorders of the nervous system
36. Current concepts of PLP and its role in the nervous system
37. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin
38. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I
39. Immune reactions in the peripheral nervous system
40. Distribution of P0 protein and the myelin-associated glycoprotein in peripheral nerves from Trembler mice
41. Human autoimmune neuropathies
42. The control of axon caliber
43. Regional modulation of neurofilament organization by myelination in normal axons
44. Neurofilament function in health and disease
45. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom
46. Induction of sodium channel clustering by oligodendrocytes
47. Sialic acids in molecular and cellular interactions
48. Effector pathways in immune mediated central nervous system demyelination
49. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells
50. Axonal pathology in multiple sclerosis. A historical note
51. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
52. Myelination in the absence of myelin-associated glycoprotein
53. Animal models for inherited peripheral neuropathies
54. Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve
55. Enhanced expression of the extracellular matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve
56. Inherited demyelinating neuropathies: From gene to disease
57. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies
58. Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier
59. Paranodin, a glycoprotein of neuronal paranodal membranes
60. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene
61. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin
62. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies
63. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin 32
64. Functional evidence for the role of axolemma in CNS myelination
65. + channels adjacent to remyelinating Schwann cells
66. Decreased axon caliber and neurofilaments in hereditary motor and sensory neuropathy type I
67. + channels
68. Axonal dystrophy as a consequence of long-term demyelination
69. Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing central nervous system
70. Role of axonal components during myelination
71. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts
72. Effects of PMP22 duplication and deletions on the axonal cytoskeleton
73. Clustering of sodium channels at the node of Ranvier: Close encounters of the axon-glia kind
74. Distal axonopathy in peripheral nerves of PMP22-mutant mice
75. Charcot-Marie-Tooth disease: Histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1)
76. Connexin32-null mice develop demyelinating peripheral neuropathy
77. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects
78. An oligodendrocyte adhesion molecule at the site of assembly of the paranodal axo-glial junction
79. Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve
80. Axonal transection in the lesions of multiple sclerosis
81. Immunocytochemical localization of the myelin-associated glycoprotein: Fact or artifact?
82. Neurodegeneration in multiple sclerosis: Relationship to neurological disability
83. Early onset of axonal degeneration in double (Plp-/-mag-/-) and hypomyelinosis in triple (Plp-/-mbp-/-mag-/-) mutant mice
84. The clustering of axonal sodium channels during development of the peripheral nervous system
85. Ion channel redistribution and function during development of the myelinated axon
86. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot-Marie-Tooth disease type 1
87. Studies on the control of myelinogenesis. I. Myelination of regenerating axons after entry into a foreign unmyelinated nerve
88. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
89. Unwrapping new layers of complexity in axon/glial relationships
90. Tenascin-R is a functional modulator of sodium channel beta subunits
91. Gangliosides are neural ligands for myelin-associated glycoprotein
92. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons
93. Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations